Stereotaxis - נכסים נקיים למניה בודדת STXS

This STXS price chart illustrates the price action of the high-precision medical systems developer, whose current metric stands at 0.13. Stereotaxis, Inc. (STXS) relies on external contractors for electronics manufacturing and logistics to support clinics. Management effectively protects intellectual property and is implementing Genesis, while modernized navigation equipment assembly shops operate seamlessly due to fully automated control.

Stereotaxis, Inc. (STXS) invests in highly skilled roboticists and complex R&D projects, which directly impacts its capital structure and asset value. By analyzing the average book value per share, an investor can determine the remaining net assets per security after deducting liabilities, allowing for an assessment of the business's intrinsic value and the adequacy of capital to maintain technological leadership without external borrowing.